Catalyst Wire Dossier Catalyst Wire Dossier

Depot-formulation subcutaneous immunotherapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Depot-formulation subcutaneous immunotherapy, covering 2017-10-23 to 2017-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea [Phase 1]

See pricing